UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 44

of 'Management of gastrointestinal lymphomas'

44
TI
Rituximab-induced remission of a gastric MALT lymphoma.
AU
Datta YH, Kampalath B, Binion DG
SO
Leuk Lymphoma. 2004;45(6):1297.
 
Gastric MALT lymphoma is usually associated with H. pylori infection, and responds to treatment with antibiotics and a proton pump inhibitor. We report a case of H. pylori negative gastric MALT lymphoma. The patient was followed conservatively for 2 years until she developed gastrointestinal bleeding with significant anemia. She was treated with rituximab 375 mg/m2 weekly for four doses, which resulted in a biopsy proven complete remission. Rituximab therapy is a reasonable, well tolerated treatment alternative for MALT lymphomas not associated with H. pylori.
AD
Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA. yhdatta@mcw.edu
PMID